Health · 1 sources covering this

STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline

Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company tries to jumpstart its pipeline.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·2h ago
STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline
Sanofi said that Paulo Fontoura, the chief medical officer at Xaira, would be taking over as its head of R&D, as the company tries to jumpstart its pipeline.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/907de36fa61a3d1358f690b008856e3441d91b57"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Sanofi names new R&#038;D head as it tries to jumpstart pipeline"></iframe>

STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline

How 1 sources are covering this

STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline

More from Health

Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers

Despite state bans, abortions have almost doubled in the U.S.

A blood test that screens for multiple types of cancer? It could be a reality soon

Serena Williams has returned to tennis. How returning to a sport can benefit you

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Sanofi names new R&#038;D head as it tries to jumpstart pipeline

More from Health

Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers

Despite state bans, abortions have almost doubled in the U.S.

A blood test that screens for multiple types of cancer? It could be a reality soon

Serena Williams has returned to tennis. How returning to a sport can benefit you

Reader

Trust & legal

Across the network

STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline